[go: up one dir, main page]

AU7615081A - Alpha amylase inhibitor - Google Patents

Alpha amylase inhibitor

Info

Publication number
AU7615081A
AU7615081A AU76150/81A AU7615081A AU7615081A AU 7615081 A AU7615081 A AU 7615081A AU 76150/81 A AU76150/81 A AU 76150/81A AU 7615081 A AU7615081 A AU 7615081A AU 7615081 A AU7615081 A AU 7615081A
Authority
AU
Australia
Prior art keywords
alpha amylase
amylase inhibitor
inhibitor
alpha
amylase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU76150/81A
Other versions
AU542795B2 (en
Inventor
Heinz Aschauer
Gerhard Braunitzer
Miroslav Mracek
Laszlo Vertesy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19803038130 external-priority patent/DE3038130A1/en
Priority claimed from DE19813107106 external-priority patent/DE3107106A1/en
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of AU7615081A publication Critical patent/AU7615081A/en
Application granted granted Critical
Publication of AU542795B2 publication Critical patent/AU542795B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU76150/81A 1980-10-09 1981-10-08 Alpha amylase inhibitor Ceased AU542795B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE30381307 1980-10-09
DE19803038130 DE3038130A1 (en) 1980-10-09 1980-10-09 Alpha amylase inactivators for Streptomyces tendae - useful for lowering blood sugar levels
DE19813107106 DE3107106A1 (en) 1981-02-26 1981-02-26 alpha -Amylase inactivator and process for its preparation
DE31071066 1981-02-26

Publications (2)

Publication Number Publication Date
AU7615081A true AU7615081A (en) 1982-04-22
AU542795B2 AU542795B2 (en) 1985-03-14

Family

ID=25788382

Family Applications (1)

Application Number Title Priority Date Filing Date
AU76150/81A Ceased AU542795B2 (en) 1980-10-09 1981-10-08 Alpha amylase inhibitor

Country Status (9)

Country Link
US (1) US4451455A (en)
EP (1) EP0049847B1 (en)
AU (1) AU542795B2 (en)
CA (1) CA1172978A (en)
DE (1) DE3169418D1 (en)
DK (1) DK446481A (en)
ES (1) ES8207217A1 (en)
FI (1) FI813108L (en)
NO (1) NO813407L (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996012730A1 (en) * 1994-10-20 1996-05-02 Industrial Research Limited Separation of amino acids and peptides from protein hydrolysates

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5885899A (en) * 1981-11-16 1983-05-23 Fujirebio Inc Amylase inhibitor and its preparation
DE3331860A1 (en) * 1983-09-03 1985-03-21 Hoechst Ag, 6230 Frankfurt Process for the preparation of tendamistat
DK520784A (en) * 1984-01-21 1985-07-22 Hoechst Ag CYCLIC POLYPEPTIDES, THEIR PREPARATION AND USE
DE3738541A1 (en) * 1987-11-13 1989-05-24 Hoechst Ag METHOD FOR INSULATING AND CLEANING HIRUDINE
DE3536182A1 (en) * 1985-10-10 1987-04-16 Hoechst Ag PROMOTOR ARRANGEMENT FOR STREPTOMYCETE VECTORS
BRPI0416639A (en) 2003-11-19 2007-01-16 Metabasis Therapeutics Inc phosphorus-containing thyromimetics
US7262318B2 (en) * 2004-03-10 2007-08-28 Pfizer, Inc. Substituted heteroaryl- and phenylsulfamoyl compounds
US20050288340A1 (en) * 2004-06-29 2005-12-29 Pfizer Inc Substituted heteroaryl- and phenylsulfamoyl compounds
EP1819681B1 (en) * 2004-11-23 2009-08-12 Warner-Lambert Company LLC 7-(2h-pyrazol-3-yl)-3,5-dihydroxy-heptanoic acid derivatives as hmg co-a reductase inhibitors for the treatment of lipidemia
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
CN101663262B (en) 2006-12-01 2014-03-26 百时美施贵宝公司 N-(3-benzyl)-2,2-(diphenyl)-propan-1amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
US7879802B2 (en) 2007-06-04 2011-02-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
AU2009256157B2 (en) 2008-06-04 2014-12-18 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
JP2011528375A (en) 2008-07-16 2011-11-17 シナジー ファーマシューティカルズ インコーポレイテッド Guanylate cyclase agonists useful for the treatment of gastrointestinal disorders, inflammation, cancer, and other disorders
US20120046364A1 (en) 2009-02-10 2012-02-23 Metabasis Therapeutics, Inc. Novel Sulfonic Acid-Containing Thyromimetics, and Methods for Their Use
CA2799708A1 (en) 2010-05-21 2011-11-24 Pfizer Inc. 2-phenyl benzoylamides
US20130156720A1 (en) 2010-08-27 2013-06-20 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
US20130345392A1 (en) 2011-03-04 2013-12-26 Pfizer Inc Edn3-like peptides and uses thereof
US20150050371A1 (en) 2012-03-09 2015-02-19 Biotropics Malaysia Berhad Extract Formulations of Rhodamnia Cinerea And Uses Thereof
AU2014235209B2 (en) 2013-03-15 2018-06-14 Bausch Health Ireland Limited Guanylate cyclase receptor agonists combined with other drugs
JP2016514671A (en) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド Guanylate cyclase agonists and uses thereof
JP2016516804A (en) 2013-04-17 2016-06-09 ファイザー・インク N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
AU2014274812B2 (en) 2013-06-05 2018-09-27 Bausch Health Ireland Limited Ultra-pure agonists of guanylate cyclase C, method of making and using same
US9708272B2 (en) 2014-08-29 2017-07-18 Tes Pharma S.R.L. Inhibitors of α-amino-β-carboxymuconic acid semialdehyde decarboxylase
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
EP3526199B1 (en) 2016-10-14 2022-04-13 Tes Pharma S.r.l. Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase
MX2021005904A (en) 2018-11-20 2021-09-08 Tes Pharma S R L INHIBITORS OF a-AMINO-ß-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE.
AU2020209215B2 (en) 2019-01-18 2023-02-02 Astrazeneca Ab PCSK9 inhibitors and methods of use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5125232B1 (en) * 1965-02-24 1976-07-29
DE2701890C2 (en) * 1977-01-19 1983-08-04 Hoechst Ag, 6230 Frankfurt Streptomycete peptic glycoside hydrolase inhibitor and its use

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996012730A1 (en) * 1994-10-20 1996-05-02 Industrial Research Limited Separation of amino acids and peptides from protein hydrolysates

Also Published As

Publication number Publication date
NO813407L (en) 1982-04-13
ES505959A0 (en) 1982-09-01
DE3169418D1 (en) 1985-04-25
US4451455A (en) 1984-05-29
EP0049847A3 (en) 1982-08-25
EP0049847B1 (en) 1985-03-20
AU542795B2 (en) 1985-03-14
CA1172978A (en) 1984-08-21
EP0049847A2 (en) 1982-04-21
ES8207217A1 (en) 1982-09-01
FI813108A7 (en) 1982-04-10
DK446481A (en) 1982-04-10
FI813108L (en) 1982-04-10

Similar Documents

Publication Publication Date Title
AU542795B2 (en) Alpha amylase inhibitor
DE3172138D1 (en) Enzyme inhibitors
AU544099B2 (en) Triazolylpentenols
AU537992B2 (en) Polusilanes
AU537459B2 (en) Alpha amylase purification
AU545667B2 (en) Diamino-pyridines
AU539188B2 (en) Skin-packaging
AU538782B2 (en) Triazoloquinoxalin-4-ones
AU536754B2 (en) Imidodisulfamides
AU554592B2 (en) Imidazolyl-phenyl amidines
AU548992B2 (en) 2-guanidno-4-heteroarylthiazoles
AU546022B2 (en) Combi-equipment
AU545397B2 (en) Cloches
AU537824B2 (en) Oxygensensor
AU541912B2 (en) 2-nitroimidazoles
AU527275B2 (en) Auto-diaphragm hemodialyser
AU542420B2 (en) Anti-rhinovirus agents
AU540787B2 (en) 4-indenyl-alkyl-piperidenes
AU543520B2 (en) Kijanimicin
AU534814B2 (en) Showstand
AU537073B2 (en) Haloacetanilide
AU538808B2 (en) Benzo(alpha)quinolizines
AU540683B2 (en) Photocomposer
AU541732B2 (en) 11a-amino-androstanes
AU517843B2 (en) Guanylamidines